In this work we confirmed that LPS phosphorylates JAK2/STAT3, ERK1/2 and P38 in neutrophils from severe asthma and COPD patients which were attenuated by LAS194046, showing synergic inhibitory effects when combined with fluticasone propionate. Here, MAPK3 is linked to chronic obstructive pulmonary disease.